Steven W. Pipe

10.8k citations

207 papers · 6.9k · 3 hit papers · h-index 40

Impact in

Hematology top 0.05%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
Genetics top 1%
- Virus-based gene therapy research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in

Hematology 162
- Hemophilia Treatment and Research 149
- Blood Coagulation and Thrombosis Mechanisms 58
- Platelet Disorders and Treatments 43
Molecular Biology 43
- Cancer-related gene regulation 20
- CRISPR and Genetic Engineering 15

Co-authors: Randal J. Kaufman (21 shared papers)Hongzhi Miao (11 shared papers)Johnny Mahlangu (21 shared papers)Anna R. Wolfson (1 shared paper)Kezhong Zhang (1 shared paper)Jyoti Malhotra (3 shared papers)Subramaniam Pennathur (1 shared paper)Angela C. Weyand (5 shared papers)
Journals: Blood (51 papers)Haemophilia (36 papers)Journal of Thrombosis and Haemostasis (19 papers)Research and Practice in Thrombosis and Haemostasis (15 papers)Blood Advances (8 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Steven W. Pipe

192 papers receiving 6.8k citations

Steven W. Pipe's Hit Papers

align trajectories log scale

WFH Guidelines for the Management of Hemophilia, 3rd edition 2020 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Haemophilia
2019 The Lancet Haematology
2008 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Steven W. Pipe

Since Specialization

Citations

This map shows the geographic impact of Steven W. Pipe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven W. Pipe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven W. Pipe more than expected).

Fields of papers citing papers by Steven W. Pipe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven W. Pipe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven W. Pipe. The network helps show where Steven W. Pipe may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven W. Pipe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven W. Pipe Line = papers co-authored together Steven W. Pipe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	WFH Guidelines for the Management of Hemophilia, 3rd edition Haemophilia ·Alok Srivastava, Elena Santagostino, Alison Dougall, Steve Kitchen, M. Linda Sutherland, Steven W. Pipe, Manuel Carção, Johnny Mahlangu, Margaret V. Ragni, Jerzy Windyga, Adolfo Llinás, N J Goddard, Richa Mohan, Pradeep Mathew Poonnoose, Brian M. Feldman, Sandra Zelman Lewis, H. Marijke van den Berg, Glenn F. Pierce, (unknown) Hit paper breakdown →	2020	1159
2	Antioxidants reduce endoplasmic reticulum stress and improve protein secretion Proceedings of the National Academy of Sciences ·Jyoti Malhotra, Hongzhi Miao, Kezhong Zhang, Anna R. Wolfson, Subramaniam Pennathur, Steven W. Pipe, Randal J. Kaufman Hit paper breakdown →	2008	581
3	Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study The Lancet Haematology ·Steven W. Pipe, Midori Shima, Michaela Lehle, Amy D. Shapiro, Sammy Chebon, Katsuyuki Fukutake, Nigel S. Key, Agnès Portron, Christophe Schmitt, Maria Podolak‐Dawidziak, Nives Selak Bienz, Cédric Hermans, Avrita Campinha‐Bacote, Anna Kiialainen, Kathelijne Peerlinck, Gallia G. Levy, Víctor Jiménez‐Yuste Hit paper breakdown →	2019	277
4	Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex Nature Genetics ·Bin Zhang, Michael Cunningham, William C. Nichols, John Bernat, Uri Seligsohn, Steven W. Pipe, John H. McVey, U. Schulte-Overberg, Norma B de Bosch, Arlette Ruiz‐Sàez, Gilbert White, (unknown), Randal J. Kaufman, David Ginsburg	2003	220
5	Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies Blood ·Michael U. Callaghan, Claude Négrier, Ido Paz‐Priel, Tiffany Chang, Sammy Chebon, Michaela Lehle, Johnny Mahlangu, Guy Young, Rebecca Kruse‐Jarres, Maria Elisa Mancuso, Markus Niggli, Monet Howard, Nives Selak Bienz, Midori Shima, Víctor Jiménez‐Yuste, Christophe Schmitt, Elina Asikanius, Gallia G. Levy, Steven W. Pipe, Johannes Oldenburg	2020	180
6	Bioengineering of coagulation factor VIII for improved secretion Blood ·Hongzhi Miao, Nongnuch Sirachainan, L. E. Palmer, Phillip Kucab, Michael Cunningham, Randal J. Kaufman, Steven W. Pipe	2004	172
7	Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A Blood ·Steven W. Pipe, Robert R. Montgomery, Kathleen P. Pratt, Peter J. Lenting, David Lillicrap	2016	162
8	New therapies for hemophilia Blood ·Angela C. Weyand, Steven W. Pipe	2018	129
9	Differential Interaction of Coagulation Factor VIII and Factor V with Protein Chaperones Calnexin and Calreticulin Journal of Biological Chemistry ·Steven W. Pipe, Jill A. Morris, Jay Shah, Randal J. Kaufman	1998	127
10	Mannose-dependent Endoplasmic Reticulum (ER)-Golgi Intermediate Compartment-53-mediated ER to Golgi Trafficking of Coagulation Factors V and VIII Journal of Biological Chemistry ·Micheline J. Moussalli, Steven W. Pipe, Hans-Peter Hauri, William C. Nichols, David Ginsburg, Randal J. Kaufman	1999	105
11	Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa Proceedings of the National Academy of Sciences ·Steven W. Pipe, Randal J. Kaufman	1997	105
12	Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B Blood Advances ·Annette von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe	2019	101
13	The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing The Lancet ·Maria Elisa Mancuso, Johnny Mahlangu, Steven W. Pipe	2021	94
14	Four Hydrophobic Amino Acids of the Factor VIII C2 Domain Are Constituents of Both the Membrane-binding and von Willebrand Factor-binding Motifs Journal of Biological Chemistry ·Gary E. Gilbert, Randal J. Kaufman, Andrew A. Arena, Hongzhi Miao, Steven W. Pipe	2002	90
15	Mild Hemophilia A Caused by Increased Rate of Factor VIII A2 Subunit Dissociation: Evidence for Nonproteolytic Inactivation of Factor VIIIa In Vivo Blood ·Steven W. Pipe, Angela N. Eickhorst, S.H. McKinley, Evgueni L. Saenko, Randal J. Kaufman	1999	86
16	Mutagenesis of a Potential Immunoglobulin-binding Protein-binding Site Enhances Secretion of Coagulation Factor VIII Journal of Biological Chemistry ·Manju Swaroop, Micheline J. Moussalli, Steven W. Pipe, Randal J. Kaufman	1997	85
17	Recombinant clotting factors Thrombosis and Haemostasis ·Steven W. Pipe	2008	79
18	Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure Journal of Thrombosis and Haemostasis ·Jialan Shi, Steven W. Pipe, Jan T. Rasmussen, Christian W. Heegaard, Gary E. Gilbert	2008	77
19	Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g Journal of Pediatric Surgery ·T. L. Trus, Andrea Winthrop, Steven W. Pipe, Jay Shah, Jacob C. Langer, George Y.P. Lau	1993	77
20	Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa Blood ·Steven W. Pipe, Evgueni L. Saenko, Angela N. Eickhorst, Geoffrey Kemball‐Cook, Randal J. Kaufman	2001	71

About Steven W. Pipe

Steven W. Pipe is a scholar working on Hematology, Molecular Biology, Genetics, Genetics and Oncology, having authored 207 papers that have together received 6.9k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (149 papers), Blood Coagulation and Thrombosis Mechanisms (58 papers), Platelet Disorders and Treatments (43 papers), Virus-based gene therapy research (27 papers), CAR-T cell therapy research (22 papers), Cancer-related gene regulation (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers) and CRISPR and Genetic Engineering (15 papers). The work is most often cited by research in Hematology (4.9k citations), Genetics (602 citations), Internal Medicine (134 citations), Genetics (911 citations) and Cell Biology (485 citations). Steven W. Pipe has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Randal J. Kaufman, Hongzhi Miao, Johnny Mahlangu, Anna R. Wolfson, Kezhong Zhang, Jyoti Malhotra, Subramaniam Pennathur, Angela C. Weyand, Glenn F. Pierce and Alok Srivastava. Their work appears in journals such as Blood, Haemophilia, Journal of Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Steven W. Pipe

Impact in

Papers in i

In The Last Decade

Steven W. Pipe

Steven W. Pipe's Hit Papers

Peers

Countries citing papers authored by Steven W. Pipe

Fields of papers citing papers by Steven W. Pipe

All Works

About Steven W. Pipe

Explore authors with similar magnitude of impact

Papers in